Lab guide · Comparisons
TB-500 vs Thymosin Beta-4: Why One Name Can Mean Two Molecules
TB-500 vs thymosin beta-4 is a question about identity: the full-length 43-residue protein and a seven-residue synthetic fragment are both sold as TB-500. This guide compares them on length, mass, formula, biology and detectability, explains how the naming problem arose, and shows how a mass measurement settles which molecule a vial contains.
Key takeaways
- Full-length thymosin beta-4 has 43 residues and a mass of about 4963.5 g/mol; the fragment sometimes sold as TB-500, Ac-LKKTETQ, has 7 residues and about 889 g/mol.
- A 2012 doping-control paper describes TB-500 as a synthetic version of an active region of thymosin beta-4 and detects N-acetylated LKKTETQ and its metabolites.
- Most mechanistic and tissue-repair findings concern the full-length protein, so they cannot be transferred to the fragment.
- A mass of about 4963 Da means full-length thymosin beta-4; a mass near 889 Da means the fragment.
TB-500 vs thymosin beta-4 at a glance
The table gives the seven differences that matter.
| # | Feature | Full-length thymosin beta-4 | TB-500 fragment (Ac-LKKTETQ) |
|---|---|---|---|
| 1 | Length | 43 residues | 7 residues |
| 2 | Sequence | Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES | Ac-LKKTETQ (residues 17-23) |
| 3 | Formula | C212H350N56O78S | C38H68N10O14 |
| 4 | Average mass | about 4963.5 g/mol | about 889.0 g/mol |
| 5 | CAS number | 77591-33-4 | Not verified in the sources reviewed |
| 6 | Biology | Binds G-actin 1:1; signalling and repair findings in cell and animal models | Contains the LKKTET actin-binding motif; direct data are sparse |
| 7 | Analytical and anti-doping | Named in WADA section S2 | Detected with its metabolites by LC-MS in a 2012 doping-control study |
Research use only. This comparison summarises published laboratory and analytical research. Baltic Peptides supplies TB-500 for in-vitro and preclinical research by qualified researchers; it is not a medicine and is not for human or veterinary use.
How the naming problem arose
Ho et al. (2012) describe TB-500 as a synthetic version of an active region of thymosin beta-4, and develop a method to detect N-acetylated LKKTETQ and its metabolites in equine urine and plasma. In that paper TB-500 is the fragment. In the research-peptide market, however, the label is also applied to full-length thymosin beta-4, so the same name appears on different molecules with different masses. The Baltic Peptides product is full-length thymosin beta-4, as described in What is TB-500.
Chemistry: what the fragment keeps and loses
Thymosin beta-4’s central actin-binding motif is LKKTET at residues 17-22, and the fragment includes it together with the next residue, Gln23, and an N-terminal acetyl cap. What it lacks is the rest of the 43-residue chain, including the N-terminal region and the C-terminal tail. A motif being present does not mean the behaviour of the whole protein is preserved, because binding depends on the surrounding structure. The fragment has no methionine, so it is chemically more robust than the full-length protein, which carries one methionine at position 6.
What the research covers
The best-established property of thymosin beta-4 is 1:1 binding to monomeric G-actin, reviewed by Goldstein et al. (2005), and later tissue-repair work is reviewed by Goldstein and Kleinman (2015). These findings concern the full-length protein. The 2012 paper concerns detection of the fragment, not its pharmacology, and no comparative biological study of the fragment against the whole protein was found in the sources reviewed.
How a mass measurement settles it
The two masses are about 4963.5 and 889.0 g/mol, so intact-mass analysis separates them at once. A certificate that reports only HPLC purity cannot, because a pure fragment and a pure protein both give a single peak. This is why a mass result matters, as explained in peptide mass spectrometry and the COA reading guide.
On a mass spectrum the two look different too. The fragment gives a singly charged ion near 889.5 m/z ([M+H]+ from the 888.492 Da monoisotopic mass), while the full-length protein, with a monoisotopic mass of about 4960.5 Da, appears as multiply charged ions such as [M+5H]5+ near 993.1 and [M+6H]6+ near 827.8. A certificate quoting a deconvoluted mass should state which species it found.
What this comparison does not show
- No direct biological comparison of the fragment and the protein was found.
- The fragment’s CAS number could not be verified here.
- Evidence for the full-length protein cannot be applied to the fragment, and the reverse.
- Neither form is an approved medicine, and both are named in the WADA Prohibited List under S2.
Sources and further reading
- Ho E.N.M. et al. (2012). Doping control analysis of TB-500, a synthetic version of an active region of thymosin beta-4, in equine urine and plasma by liquid chromatography-mass spectrometry. J Chromatogr A. PubMed
- Goldstein A.L. and Kleinman H.K. (2015). Advances in the basic and clinical applications of thymosin beta-4. PubMed
- Goldstein A.L. et al. (2005). Thymosin beta-4: actin-sequestering protein moonlights to repair injured tissues. PubMed
- PubChem: Thymosin beta 4 (CID 45382195). PubChem
All Baltic Peptides products are supplied strictly for laboratory research use. They are not medicines, supplements or food and are not for human or animal use. This article explains analytical and chemical concepts and is for educational purposes only.
FAQ
Common questions
What is the difference between TB-500 and thymosin beta-4?
Is TB-500 the same as thymosin beta-4?
How can you tell which one a vial contains?
What is the sequence of the TB-500 fragment?
Does the fragment behave like thymosin beta-4?
How was the TB-500 fragment detected in doping control?
Are TB-500 and thymosin beta-4 approved medicines?
Keep reading
Related reading
What is TB-500?
Thymosin beta-4 and the TB-500 naming problem.
BPC-157 vs TB-500
Two unrelated peptides compared side by side.
Peptide mass spectrometry
How a mass measurement settles identity.
Research-grade TB-500, tested before it ships
Independent HPLC and mass spec results for every batch, dispatched from the EU.
